Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on May 9, 2025

Argus Research

2 days ago

RVTY: Lowering target price to $95.00

3 S&P 500 Stocks in the Doghouse

StockStory

3 days ago

3 S&P 500 Stocks in the Doghouse

MT Newswires

8 days ago

UBS Upgrades Revvity to Buy from Neutral, Cuts Price Target to $115 From $145

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

StockStory

8 days ago

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

MT Newswires

9 days ago

KeyBanc Adjusts Revvity's Price Target to $135 From $145

Revvity to Present at Upcoming Investor Conferences

Business Wire

9 days ago

Revvity to Present at Upcoming Investor Conferences

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

StockStory

9 days ago

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St.

10 days ago

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

MT Newswires

10 days ago

Baird Adjusts Price Target on Revvity to $125 From $127, Maintains Outperform Rating

MT Newswires

10 days ago

Raymond James Adjusts Price Target on Revvity to $120 From $145, Maintains Outperform Rating

MT Newswires

10 days ago

JPMorgan Adjusts Price Target on Revvity to $100 From $120, Maintains Neutral Rating

MT Newswires

10 days ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

MT Newswires

10 days ago

TD Cowen Adjusts Price Target on Revvity to $126 From $122, Maintains Buy Rating

MT Newswires

10 days ago

Goldman Sachs Adjusts Price Target on Revvity to $125 From $140, Maintains Buy Rating

Company News for Apr 29, 2025

Zacks

10 days ago

Company News for Apr 29, 2025

MT Newswires

11 days ago

Evercore ISI Adjusts Price Target on Revvity to $116 From $125

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Investopedia

11 days ago

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

11 days ago

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

MT Newswires

11 days ago

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires

11 days ago

Sector Update: Health Care

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Reuters

11 days ago

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

Zacks

11 days ago

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

MT Newswires

11 days ago

Revvity Q1 Adusted Earnings, Revenue Increase; 2025 Revenue Outlook Lifted

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Zacks

14 days ago

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Zacks

14 days ago

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Revvity Board Declares Quarterly Dividend

Business Wire

14 days ago

Revvity Board Declares Quarterly Dividend

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Zacks

16 days ago

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

3 Cash-Producing Stocks Skating on Thin Ice

StockStory

16 days ago

3 Cash-Producing Stocks Skating on Thin Ice

Argus Research

16 days ago

RVTY: Lowering target price to $97.00

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Zacks

18 days ago

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

MT Newswires

22 days ago

Leerink Partners Adjusts Price Target on Revvity to $135 From $140, Keeps Outperform Rating

MT Newswires

22 days ago

Wells Fargo Adjusts Price Target on Revvity to $102 From $130, Keeps Equalweight Rating

MT Newswires

23 days ago

Bernstein Adjusts Price Target on Revvity to $120 From $140, Maintains Market Perform Rating

Argus Research

23 days ago

RVTY: Raising target price to $100.00

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

Simply Wall St.

24 days ago

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

MT Newswires

25 days ago

BofA Securities Cuts Price Target on Revvity to $116 From $143, Maintains Buy Rating

MT Newswires

a month ago

KeyBanc Lowers Price Target on Revvity to $135 From $145

Morningstar Research

a month ago

Analyst Report: Revvity, Inc.

MT Newswires

a month ago

Barclays Adjusts Price Target on Revvity to $110 From $140

MT Newswires

a month ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating

Argus Research

a month ago

RVTY: Lowering target price to $96.00

Revvity to Hold Earnings Call on Monday, April 28, 2025

Business Wire

a month ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

Medical Device Network

a month ago

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

MT Newswires

a month ago

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating

MT Newswires

a month ago

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Business Wire

a month ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

a month ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

a month ago

RVTY: Lowering target price to $110.00

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

a month ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Argus Research

a month ago

RVTY: Lowering target price to $113.00

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Simply Wall St.

a month ago

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Zacks

2 months ago

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Morningstar Research

2 months ago

Analyst Report: Revvity, Inc.

MT Newswires

2 months ago

Revvity Expands Alliance with Genomics England

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Business Wire

2 months ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

MT Newswires

2 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Simply Wall St.

2 months ago

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Argus Research

2 months ago

RVTY: Lowering target price to $87.00

MT Newswires

2 months ago

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Business Wire

2 months ago

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

StockStory

2 months ago

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Revvity Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

2 months ago

Revvity Full Year 2024 Earnings: In Line With Expectations

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

StockStory

2 months ago

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Zacks

2 months ago

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Argus Research

2 months ago

RVTY: Raising target price to $92.00

MT Newswires

3 months ago

Revvity Wins Permanent Injunction Against Cloud Software Group

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Business Wire

3 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity to Present at Upcoming Investor Conferences

Business Wire

3 months ago

Revvity to Present at Upcoming Investor Conferences

Argus Research

3 months ago

RVTY: Rating decreased to a SELL

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Insider Monkey

3 months ago

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

3 months ago

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Argus Research

3 months ago

RVTY: Lowering target price to $129.00

MT Newswires

3 months ago

Raymond James Adjusts Price Target on Revvity to $145 From $140

MT Newswires

3 months ago

KeyBanc Adjusts Revvity Price Target to $145 From $132

MT Newswires

3 months ago

Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

GuruFocus.com

3 months ago

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Revvity Inc Earnings Call

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

StockStory

3 months ago

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

Morningstar Research

3 months ago

Analyst Report: Revvity, Inc.

MT Newswires

3 months ago

Citigroup Raises Price Target on Revvity to $155 From $145

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

Zacks

3 months ago

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

MT Newswires

3 months ago

Evercore ISI Adjusts Price Target on Revvity to $138 From $125

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

3 months ago

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Revvity (RVTY) Surpasses Q4 Earnings Estimates

Zacks

3 months ago

Revvity (RVTY) Surpasses Q4 Earnings Estimates

MT Newswires

3 months ago

Revvity Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Up Pre-Bell

Associated Press Finance

3 months ago

Revvity: Q4 Earnings Snapshot

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Business Wire

3 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Zacks

3 months ago

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Argus Research

3 months ago

RVTY: Raising target price to $132.00

MT Newswires

3 months ago

Baird Adjusts Revvity Price Target to $137 From $138, Maintains Outperform Rating

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Barrons.com

3 months ago

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Revvity Board Declares Quarterly Dividend

Business Wire

4 months ago

Revvity Board Declares Quarterly Dividend

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Zacks

4 months ago

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Argus Research

4 months ago

RVTY: Raising target price to $130.00

MT Newswires

4 months ago

Raymond James Adjusts Revvity Price Target to $140 From $146

Argus Research

4 months ago

RVTY: Raising target price to $127.00

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Zacks

4 months ago

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Business Wire

4 months ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Share on Social Networks: